Astrazeneca Pharma India Ltd.
ASTRAZEN Share PricePharmaceuticals & Drugs
₹9,045.5
-44.5 (-0.5%)
As on September 8, 2025
Exchange Scrips: BSE506820NSEASTRAZENISININE203A01020
Market Cap ₹ 22,503 Cr
P/E Ratio 195.38
Dividend Yield 0.18 %
Performance
Market performance
Open9,120
High9,152.5
Volumes12,381
Prev9,045.5
Low8,909.5
As on2025-09-08
Historical performance
1 Year High10,691
3 Year High10,691
5 Year High10,691
1 Year Low6,220
3 Year Low2,911
5 Year Low2,445.7
Fundamentals
Company Valuation
Market Cap (₹Cr)
22,503
Face Value (₹)
2
P/E Ratio
195.38
Dividend Yield
0.18 %
Investment Returns
1 Year
31.4%
3 Years
196.2%
5 Years
113.8%
10 Years
660.1%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 9,053.9 | Bearish |
| 10-DMA | 8,710.75 | Bullish |
| 20-DMA | 8,612.15 | Bullish |
| 50-DMA | 8,875.57 | Bullish |
| 100-DMA | 8,828.91 | Bullish |
| 200-DMA | 8,017.94 | Bullish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 1 | 1 | 1 | 1 | 1 |
| Foreign Investors | 1 | 1 | 1 | 1 | 1 |
| Domestic Investors | --- | --- | --- | --- | --- |
| Public Investors | 34377 | 32465 | 27321 | 27614 | 27168 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 195.38.
- 3Y Stock Price CAGR of the stock is 42.9.
- The stock has a beta of 0.3.
- In the last financial year, the company had an EBITDA of ₹2946 Million.
- The company generated revenue of ₹17163 Million in the previous financial year.
Astrazeneca Pharma India Ltd.
9045.5-44.5 (-0.5%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1331620.7
No. of Shares: 147 (Approx)
Performance:33.2%
P/L: ₹331620.7
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent